Nuclear Imaging

brain SPECT imaging, dementia, depression, Daniel G. Amen

Representative brain SPECT scans in a patient with Alzheimer's dementia showing substantially reduced brain blood flow in the temporal and parietal lobes compared to a person with depression with mild decreased frontal lobe blood flow. Image courtesy of Amen Clinics.

News | SPECT Imaging | February 22, 2017

February 22, 2017 — Does a patient have depression or a cognitive disorder (CD) such as Alzheimer's disease or both...

News | Radiopharmaceuticals and Tracers | February 16, 2017

Cerveau Technologies Inc. announced it has signed an agreement with Siemens’ PETNET Solutions Inc. that grants the...

Blue Earth Diagnostics, Axumin, fluciclovine F-18, recurrent prostate cancer, Simens PETNET Solutions, increased patient access
News | Radiopharmaceuticals and Tracers | February 07, 2017

Blue Earth Diagnostics and Siemens’ PETNET Solutions announced that an increasing number of radiopharmacies will...

radiotargeted therapy, SST2 antagonists, combat cancer, neuroendocrine tumors, NETs, Journal of Nuclear Medicine study

Comparative receptor autoradiography in various cancer types (A = HE staining) with I-125-JR11 (B+C) and I-125-Tyr3-octreotide (D+E). B and D are the respective total binding, C and E the respective non-specific binding. Bars = 1 mm.

I: Breast cancer. II: Renal cell cancer. III: Medullary thyroid cancer. IV: Non-Hodgkin lymphoma. V: Colon cancer. In cancers I-V, the sections were incubated with 30’000 cpm/100 μl of antagonist or agonist. Cancers I-IV show a much higher density of sst2 with the antagonist. The colon cancer V is negative. VI: Ileal NET, incubated with 10’000 cpm/100 μl of antagonist or agonist. Credit: Jean Claude Reubi, Institute of Pathology, University of Berne, Berne, Switzerland. 

News | Radiation Therapy | February 06, 2017

A study published in the February issue of The Journal of Nuclear Medicine demonstrates the potential of extending...

PET/CT, primary and metastatic prostate cancer, Journal of Nuclear Medicine study, JNM

Ga-68-BBN PET/CT of a 64-year-old man newly diagnosed with prostate cancer by biopsy. Multiple bone metastasis lesions (arrows) were detected. Image courtesy of Jingjing Zhang, Peking Union Medical College, Beijing, China.

News | Prostate Cancer | February 02, 2017

In the featured article from the February 2017 issue of the Journal of Nuclear Medicine, researchers document the...

IBA Molecular, acquisition, Mallinckrodt Nuclear Imaging, nuclear imaging
News | Nuclear Imaging | January 30, 2017

IBA Molecular has successfully completed its acquisition of Mallinckrodt Nuclear Imaging, announced in August 2016,...

Gamma Medica, LumaGEM molecular breast imaging system, MBI technology, Major Health Partners Indiana
News | Breast Imaging | January 26, 2017

Gamma Medica recently announced that through its collaboration with Ohio-based Alpha Imaging, Indiana-based Major...

News | PET Imaging | January 25, 2017

In work published this week in the Journal of Clinical Investigation (JCI), a team led by Jacob Hooker at Harvard...

stress, brain activity, cardiovascular risk, PET-CT, MGH, ISSMS, The Lancet study
News | Neuro Imaging | January 18, 2017

A study led by Massachusetts General Hospital (MGH) and Icahn School of Medicine at Mount Sinai (ISSMS)...

News | Radiopharmaceuticals and Tracers | January 17, 2017

NorthStar Medical Technologies LLC has received additional matching funds from the U.S. Department of Energy’s ...

Medrad Intego PET Infusion System, recall
News | Nuclear Imaging | January 12, 2017

January 12, 2017 — Bayer Healthcare has initiated a recall of all its Medrad Intego PET Infusion System Source...

Mirada Medical, RSNA 2016, XD:PACS, molecular imaging, nuclear imaging
Technology | PACS | January 06, 2017

Mirada Medical showcased its latest XD:PACS (picture archiving and communication system) range of molecular imaging...

SPECT-CT, 3-D printing, University of Wurzburg, Germany, Johannes Tran-Gia, dosimetry calibration

SPECT/CT reconstructions and VOIs used for determination of calibration factors for the adult kidney filled with Lu-177 (A) and the corresponding sphere filled with I-131 (B). Credit: University of Würzburg

News | 3-D Printing | January 06, 2017

In nuclear medicine, the goal is to keep radiation exposure at a minimum, while obtaining quality images. Optimal...

News | Radiopharmaceuticals and Tracers | January 06, 2017

New research demonstrates that a novel imaging agent can quickly and accurately detect metastasis of prostate cancer...

Nuclear cardiology, dose reduction, myocardial perfusion imaging
News | Nuclear Imaging | January 05, 2017

January 5, 2017 — Working in concert, the American Society of Nuclear Cardiology (ASNC), the Intersocietal...

metastatic colorectal cancer, mCRC, Sirtex, NCCN guidelines, Y-90 microspheres
News | Radiation Therapy | January 03, 2017

Sirtex Medical Limited announced in December that SIR-Spheres Y-90 resin microspheres have been included as a...

SNMMI Develops USP Recommendations for Compounded Sterile Radiopharmaceuticals
News | December 28, 2016

December 28, 2016 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has developed United States...

prostate, CT scan
News | Prostate Cancer | December 22, 2016

Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics...

News | Prostate Cancer | December 14, 2016

Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on small molecules that...

News | Nuclear Imaging | December 12, 2016

Molecular Targeting Technologies, Inc. (MTTI) announces that response of colorectal cancer to treatment can be...

Overlay Init